Acute Exacerbation of Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
A Phase 2a Randomized, Doubled-Blind, Placebo-Controlled Trial to Evaluate Safety, Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
AECOPD is a major cause of hospital admission and mortality. They contribute to long-term decline in lung function, physical capacity, and quality of life (QoL). RLS-0071 is a novel peptide being developed for the treatment of AECOPD. This study is designed to evaluate the safety and tolerability of RLS-0071 in the treatment of adults with moderate exacerbations of COPD.
This is a randomized, double-blind, placebo controlled trial in hospitalized participants with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) to evaluate the safety, tolerability, preliminary efficacy, PK, and PD of RLS-0071 compared to Placebo in the treatment of AECOPD. The dosing regimen will be 3 times a day for at least 3 days and up to 5 days total if still hospitalized. Participants will be followed for efficacy and safety for 30 and 60 days after the final dose. RLS-0071 or Placebo will be given as add-on therapy to SOC management for acute exacerbations of COPD. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04044625 -
Effects of High-intensity Noninvasive Positive Pressure Ventilation in AECOPD
|
N/A | |
| Active, not recruiting |
NCT03751670 -
Pulmonary Rehabilitation During Acute Exacerbations of Chronic Obstructive Pulmonary Disease: a Mixed-methods Approach
|
N/A | |
| Completed |
NCT03083418 -
The Effect of EDP on Diaphragmatic Function and Neural Respiratory Drive in Patient With AECOPD
|
N/A | |
| Recruiting |
NCT04183530 -
The Individualized Accurate Diagnosis and Treatment of Chronic Objective Pulmonary Disease(COPD) Patients Based on Multidimensional Data
|
||
| Enrolling by invitation |
NCT06189586 -
Comparison of Aerosol Inhalation and Intravenous Glucocorticoid in the Treatment of Severe AECOPD
|
N/A | |
| Recruiting |
NCT06134063 -
A Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
|
N/A | |
| Not yet recruiting |
NCT06114667 -
Nasal High Flow Versus Non-invasive Ventilation for Early Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Hypercapnic Acidosis
|
N/A | |
| Not yet recruiting |
NCT05222711 -
The Use of a Monitoring Device by General Practitioners During Out-of-hours Care
|
N/A | |
| Recruiting |
NCT05480566 -
Functional Strength Training and Neuromuscular Electrical Stimulation in Severe Acute Exacerbations of COPD
|
N/A | |
| Terminated |
NCT02985918 -
High-Intensity vs Low-Intensity NPPV in Patients With an AECOPD: The HAPPEN Trial
|
N/A | |
| Completed |
NCT04316312 -
The Inspiratory Muscle Activation Pattern and Training Efficacy in Patients With Chronic Obstructive Pulmonary Disease After Acute Exacerbation
|
N/A | |
| Recruiting |
NCT04259736 -
Prospective Cohort Study of Molecular Mechanism of Lower Respiratory Tract Microbes in Patients With AECOPD
|
||
| Completed |
NCT03633838 -
Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in China
|
||
| Completed |
NCT02051166 -
Clinical Practice of AECOPD Management in China
|
N/A | |
| Recruiting |
NCT04212182 -
The Physiological Effect of High Flow Oxygen Therapy
|
N/A | |
| Recruiting |
NCT04101500 -
Effect of Compound Sodium Chlorate and Aminophylline Tablets on Chronic Obstructive Pulmonary Disease(COPD).
|
Phase 4 |